Sensex pares gains to turn flat, Nifty slips in red in late afternoon trade

The S&P BSE Midcap and the S&P BSE Smallcap indices outperformed to gain 0.5% and 0.8%, respectively

bse, sensex, stock, share, rally
bse, sensex, stock, share, rally
SI Reporter New Delhi
Last Updated : Jun 13 2017 | 3:01 PM IST
The benchmark indices pared initial gains to turn flat in late morning deals after much softer-than-expected inflation data fuelled hopes of an interest rate cut by the Reserve Bank of India (RBI) at its next policy review in August.

At 2:53 pm, the S&P BSE Sensex was trading at 31,125, up 29 points, while the broader Nifty50 was ruling at 9,617, up 0.8 points. 

In the broader market, the S&P BSE Midcap and the S&P BSE Smallcap indices gained 0.2% and 0.5%, respectively. 

The market breadth, indicating the overall health of the market, was strong. On the BSE, 1,452 shares rose and 851 shares fell. A total of 144 shares were unchanged.

Data released late on Monday showed consumer inflation eased to 2.18% in May, helped by a drop in food prices. It was lowest since the country started publishing an economy-wide consumer price index in 2012. 

"CPI inflation continues to be benign and seems set to dip below the RBI’s inflation target band of 2-6% as early as June. A combination of favorable base effects as well as softness in price momentum is contributing to low inflation prints in 1HFY18. Given the expected June inflation and the softer policy tone in the RBI’s June policy, we expect a 25 bps cut in the next (August) MPC meeting," said brokerage Kotak Institutional Equities in a report. 

Stocks of rate-sensitive sectors such as realty, auto and banking were moving higher. 

Nifty Realty index (up 0.8%) was the leading sectoral gainer, led by gains in Godrej Properties (4.5%), Delta Corp (1.8%) and Phoenix (1.2%). 

Nifty Bank and Nifty Auto indices were also up 0.5% and 0.3%, respectively.  

Sun Pharma rose over 1% to Rs 551 after the company said one of its wholly-owned subsidiaries received US drug regulator's approval for generic Zetia tablets. The announcement was made before trading hours today, 13 June 2017.

DIC India was locked in its upper circuit of 20% at Rs 544 on the BSE after the specialty chemicals company said its board has approved the disposal of Mumbai land.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story